Bottom line
What is MLVAX's expense ratio?
MLVAX's expense ratio is 0.89%, or about $89 a year on every $10,000 invested. That is more expensive than 55% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Dec 29, 2025
MLVAX fee table
| Net expense ratio | 0.89% |
|---|---|
| Gross expense ratio | 0.93% |
| Management fee | 0.5% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.18% |
| Fee waiver / reimbursement | -0.04% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 29, 2025
What MLVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MLVAX | $661 | $851 | $1,056 | $1,649 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.89% expense ratio costs roughly $49,800 in lost growth, versus about $46,700 for the median large blend fund (0.83%).